Michael R. Cassidy, MD

Assistant Professor, Surgery

Michael Cassidy
617.414.8090
88 East Newton Street

Biography

Michael Cassidy, MD is an Assistant Professor of Surgery at Boston University School of Medicine and a Surgical Oncologist at Boston Medical Center. He is board certified by the American Board of Surgery in both General Surgery and Complex General Surgical Oncology. Dr. Cassidy earned his undergraduate and medical degrees at Boston University. He completed residency training in surgery at Boston Medical Center, including a research fellowship in surgical quality improvement and patient safety. He then completed a clinical fellowship in Complex General Surgical Oncology at Memorial Sloan Kettering Cancer Center in New York City, where he was elected Chief Fellow. Dr. Cassidy has received local and national awards for the impact of his research, clinical care, and teaching. He has particular interest and advanced training in the care of patients with breast cancer, melanoma, and soft tissue sarcoma.

Education

  • Boston University School of Medicine, MD
  • Boston University, BA

Publications

  • Published on 12/3/2019

    Kim NE, Conway-Pearson L, Kavanah M, Mendez J, Sachs TF, Drake FT, Ko NY, McAneny D, Cassidy MR. Standardized Risk Assessment and Risk-Stratified Venous Thromboembolism Prophylaxis for Patients Undergoing Breast Operation. J Am Coll Surg. 2019 Dec 03. PMID: 31809861.

    Read at: PubMed
  • Published on 12/1/2019

    Feeney T, Cassidy M, Tripodis Y, McAneny D, Kavanah M, Sachs T, Tseng JF, Drake FT. Correction to: Association of Primary Language with Outcomes After Operations Typically Performed to Treat Cancer: Analysis of a Statewide Database. Ann Surg Oncol. 2019 12; 26(Suppl 3):887-888. PMID: 31313031.

    Read at: PubMed
  • Published on 10/17/2019

    Festa K, Hirsch AE, Cassidy MR, Oshry L, Quinn K, Sullivan MM, Ko NY. Breast Cancer Treatment Delays at an Urban Safety Net Hospital Among Women Experiencing Homelessness. J Community Health. 2019 Oct 17. PMID: 31625050.

    Read at: PubMed
  • Published on 6/15/2019

    Sridhar P, Misir P, Kwak H, deGeus SW, Drake FT, Cassidy MR, McAneny DA, Tseng JF, Sachs TE. Impact of Race, Insurance Status, and Primary Language on Presentation, Treatment, and Outcomes of Patients with Pancreatic Adenocarcinoma at a Safety-Net Hospital. J Am Coll Surg. 2019 Oct; 229(4):389-396. PMID: 31212101.

    Read at: PubMed
  • Published on 6/11/2019

    Feeney T, Cassidy M, Tripodis Y, McAneny D, Kavanah M, Sachs T, Tseng JF, Drake FT. Association of Primary Language with Outcomes After Operations Typically Performed to Treat Cancer: Analysis of a Statewide Database. Ann Surg Oncol. 2019 Sep; 26(9):2684-2693. PMID: 31187361.

    Read at: PubMed
  • Published on 11/9/2018

    Cassidy MR, Lefkowitz RA, Long N, Qin LX, Kirane A, Sbaity E, Hameed M, Coit DG, Brennan MF, Singer S, Crago AM. Association of MRI T2 Signal Intensity With Desmoid Tumor Progression During Active Observation: A Retrospective Cohort Study. Ann Surg. 2018 Nov 09. PMID: 30418203.

    Read at: PubMed
  • Published on 8/10/2018

    Morgan R, Cassidy M, DeGeus SWL, Tseng J, McAneny D, Sachs T. Presentation and Survival of Gastric Cancer Patients at an Urban Academic Safety-Net Hospital. J Gastrointest Surg. 2019 Feb; 23(2):239-246. PMID: 30097966.

    Read at: PubMed
  • Published on 1/8/2018

    Cassidy MR, Zabor EC, Stempel M, Mehrara B, Gemignani ML. Does response to neo-adjuvant chemotherapy impact breast reconstruction? Breast J. 2018 07; 24(4):567-573. PMID: 29316048.

    Read at: PubMed
  • Published on 10/16/2017

    Gholami S, Cassidy MR, Kirane A, Kuk D, Zanchelli B, Antonescu CR, Singer S, Brennan M. Size and Location are the Most Important Risk Factors for Malignant Behavior in Resected Solitary Fibrous Tumors. Ann Surg Oncol. 2017 Dec; 24(13):3865-3871. PMID: 29039030.

    Read at: PubMed
  • Published on 3/24/2017

    Cassidy MR, Wolchok RE, Zheng J, Panageas KS, Wolchok JD, Coit D, Postow MA, Ariyan C. Neutrophil to Lymphocyte Ratio is Associated With Outcome During Ipilimumab Treatment. EBioMedicine. 2017 Apr; 18:56-61. PMID: 28356222.

    Read at: PubMed

View 12 more publications: View full profile at BUMC

View all profiles